Linda Gojenola

Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer

Everett J. Moding, Yufei Liu, Barzin Y. Nabet et al. · Nature Cancer · 2020 · 370 citations · Full text

Medicine, Immunology, Oncology +17

Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition

Barzin Y. Nabet, Mohammad Shahrokh Esfahani, Everett J. Moding et al. · Cell · 2020 · 363 citations · Full text

Life Sciences, Immunology, Oncology +16

Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms

David A. Hinds, Kimberly E. Barnholt, Ruben A. Mesa et al. · Blood · 2016 · 268 citations · Full text

Medicine, Genetics, Hematology +14

<i>KEAP1/NFE2L2</i> Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition

Michael S. Binkley, Young-Jun Jeon, Monica Nesselbush et al. · Cancer Discovery · 2020 · 173 citations · Full text

Medicine, Molecular Biology, Oncology +17

Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC

Matthew D. Hellmann, Barzin Y. Nabet, Hira Rizvi et al. · Clinical Cancer Research · 2020 · 123 citations · Full text

Medicine, Molecular Medicine, Oncology +17